Category Archives: The Charlton Centre

Charlton Health specializes in supporting the management of many autoimmune and immune-mediated conditions. Recently, a treatment has become available for vitiligo, an autoimmune condition with a great unmet need. Vitiligo is an autoimmune condition in which the immune system targets … Continue reading →

As we wrap up 2024, we want to wish everyone joy this holiday season, no matter which tradition(s) you celebrate. Spending time with family and friends is the greatest gift for our health and well-being—one that no medication can replace! … Continue reading →

We often hear patients ask how they got an immune-mediated condition.  Autoimmune diseases occur when the immune system mistakenly attacks the body’s own cells, leading to long-term inflammation and damage. While genetics play a role in the development of these … Continue reading →

RSV is a seasonal virus that can cause serious lung infections, especially in young children under 2 years old and adults over 60.  Recently, Health Canada expanded the use of the Arexvy vaccine to include adults aged 50–59 who have … Continue reading →

In the summer, we wrote about the newest pneumococcal vaccine approved in the United States.  It is now available in Canada and is called Capvaxive and is manufactured by Merck. There are about 100 types of pneumococcal bacteria.  Capvaxive protects … Continue reading →

As newer biologic medicines can be incredibly useful in managing many conditions (e.g. immune-mediated, bone disorders, diabetes), their use can be limited by cost.  The introduction of biosimilars, however, has offered biologic medicines that are just as safe and effective … Continue reading →

Living with an immune-mediated condition can be a difficult journey with many different treatments. For instance, patients with rheumatoid arthritis may begin their treatment with medications such as methotrexate, leflunomide, sulfasalazine, or hydroxychloroquine, but eventually have their doctor suggest trying a more advanced treatment. These … Continue reading →

Cancer treatments have greatly evolved to offer better results with fewer adverse effects. A newer family, called Immune Checkpoint Inhibitors (ICPis), falls under this category. ICPis are a type of immunotherapy for various cancers such as multiple myeloma, non-small cell … Continue reading →

Vaccines are important in protecting us from many types of bacterial pneumonia, which can lead to serious illness including hospitalization and death. To increase protection, Ontario’s publicly funded pneumonia vaccine program now provides Prevnar 20 to adults 65 years of … Continue reading →

Last month we celebrated World Hepatitis Day. At Charlton Health, we are pleased to provide treatment for Hepatitis C and wanted to share more information about this virus. Hepatitis refers to inflammation of the liver, often caused by a viral … Continue reading →